KAI analyses conversations in the healthcare value chain. Conversations between Pharma field teams with healthcare professionals, and clinicians with patients. Our mission is to reveal hidden human insight that enabled better conversations and improved health outcomes. We're passionate about making AI available to everyone for good. If people have better conversations we know they'll have richer human relationships, the right information will be shared and patients will engage better with their treatments. We want to work with innovators who are unhappy with the status quo, that want to move from analogue to digital.

We help pharma teams make faster, smarter decisions by unifying the most critical sources of insight — including field activity, HCP engagement, social sentiment, claims data, congresses, and more — into a single, decision-ready view of the market. Powered by Know Everything™, Within3 accelerates time-to-insight and delivers precise, actionable intelligence that drives measurable impact across brand, medical, and field teams.

Trusted by all the top 20 pharmaceutical companies, Within3 enables life sciences organizations to move at the speed of launch — without sacrificing insight or clarity.

Onomi is the event-powered omnichannel platform for life sciences. It helps medical and commercial teams deliver compliant, personalized HCP and patient experiences across webinars, advisory boards, congresses, and standalones. Built CRM-first, Onomi integrates with Veeva and Salesforce to capture engagement data, enable timely follow-up, and measure impact. With over 22 years of experience, Onomi is trusted by 15 of the top 20 life sciences companies.

Matt is Founder and CEO of performance.io and a digital transformation leader with over 24 years of experience in pharma and life sciences. He began client-side before leading Global Digital Operations at a network agency and has gone on to deliver several industry firsts that have become the manifesto for how pharma companies deliver online customer engagement strategies that drive sales and a competitive advantage.

His team at performance.io has in no small way rewritten the industry rules for smashing omnichannel targets whilst releasing tens of millions in wasted spend, and as a result, performance.io has become the go-to partner of choice for SEO, GEO, and high-performance, enterprise content at scale across AstraZeneca, Sanofi, J&J, Novo Nordisk, Novartis, GSK, ViiV, Biogen, MSD, Genmab, LEO, BMS, and many more.

For an industry that is often telling us what we can’t do, Matt is the one out there doing it, so if you want to hear someone smash down the bastions of excuses for why we aren’t seeing impact, come to this session…

OEM is a specialist healthcare branding and creative agency that helps life science organisations stand out with bold strategy, sharp storytelling, and unforgettable design. Blending scientific understanding with creative flair, OEM builds brands that cut through complexity, connect with audiences, and inspire action. From positioning to visual identity to campaign activation, they partner with healthcare innovators to turn insight into impact - and ensure every message lands with clarity and conviction.

PharmaForceIQ is an end-to-end, real-time customer engagement platform that finally unifies brand and field. We empower you to predict and orchestrate the most effective, personalized, and relevant journey for every customer across channels. Clear metrics prove impact fast and immediately, including script lift. This is a bold alternative to media agencies and fragmented vendor platforms that are often over-complicated, one-size-fits-all, slow, or incentivized by higher spend. No overpromising, no frustrating implementation–just strategic partnership, sophisticated tech linked to your existing stack, and agile execution to help your team win.

Inizio is a global strategic partner for the life sciences industry, uniting scientific depth, strategic insight, and world-class execution to accelerate healthcare innovation. With expertise spanning medical, marketing, engagement, and patient experience, Inizio helps organisations navigate complexity, communicate value, and bring transformative therapies to the people who need them most. Through integrated capabilities and a deeply collaborative approach, Inizio supports life sciences companies from early development to launch and beyond - turning bold ideas into meaningful impact.

At Amplity, we’re your allies in excellence—driven to outperform because pharma partners require the best. We build expert-led teams that deliver: dedicated, high-touch business and therapeutic experts who integrate seamlessly as an extension of your operations. We develop strategic blueprints and execute with precision to drive measurable ROI and the behavioral change needed for success—for partners, providers, and patients. You’ll see us at Pharmageddon, sharing what works. We do it quicker, better, and nicer than anyone else.

We’re excited to be part of this important conversation, and we look forward to learning, sharing, and growing with you at Pharmageddon. Together, we can navigate the challenges ahead and build a stronger, healthier future.

BGB Group is a commercial solutions company that partners with pharmaceutical, biotech, and medical device companies to navigate complex challenges. With integrated capabilities, including strategic advisory, market access, medical communications, and advertising, and a commitment to client success, BGB Group helps clients achieve meaningful outcomes that improve patient lives. Learn more at bgbgroup.com.

Folia Is the industry's definition of patient-centered research achieving its full potential? Yes we have more patient involvement in research, but is it as transformative as it could be? Trial endpoints are frequently mis-aligned, a one-size-fits-all approach to measurement is the standard, and patients are struggling to see the value of participating in research. By embracing a model that provides patients with research tools that are personalized, engaging, and rooted in trust, there’s a deeper level of collaboration possible to drive innovative patient-centered research. Folia is thrilled to partner with Pharmageddon to pioneer methods that maximize the value of patient-led research for all stakeholders.

WellSky connects care — across thousands of providers, payers and communities throughout the US. uMed builds research registries that keep patients involved long after a single study closes. Together, they're one of the more interesting partnerships in this space: a company that understands how care is delivered at scale, and one that understands how to keep patients meaningfully engaged over time. They're here because they think the industry is leaving something important on the table — and they have a view on what to do about it.

WellSky connects care — across thousands of providers, payers and communities throughout the US. uMed builds research registries that keep patients involved long after a single study closes. Together, they're one of the more interesting partnerships in this space: a company that understands how care is delivered at scale, and one that understands how to keep patients meaningfully engaged over time. They're here because they think the industry is leaving something important on the table — and they have a view on what to do about it.